Inception Return
(9/10/2013)
|
10.16 %
|
|
YTD Return
|
11.10 %
|
|
NAVPS
(11/11/2026)
|
$27.09
|
|
Change
|
$0.28 / 1.04 %
|
|
|
Growth of $10,000
(As of October 31, 2026)
|
|
MER
|
2.12 %
|
|
Assets ($mil)
|
$561.96
|
|
Rank (1Yr)
|
358/1338
|
|
Std Dev (3Yr)
|
8.96 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The fundamental investment objective is to seek to achieve long-term capital appreciation by investing primarily in, or gaining exposure to, equity securities of issuers in the United States, while seeking to reduce volatility. The fundamental investment objective may only be changed with the approval of a majority of unitholders, given at a meeting called for that purpose.
|
Fund Manager
TD Asset Management Inc.
Portfolio Manager
Julien Palardy, TD Asset Management Inc.
Emin Baghramyan, TD Asset Management Inc.
Sub-Advisor
-
|
|
Asset Allocation
(As of October 31, 2026)
|
Sector Allocation
(As of October 31, 2026)
|
Geographic Allocation
(As of October 31, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Abbvie Inc | US Equity | Healthcare | United States | 1.52% |
| Visa Inc Cl A | US Equity | Financial Services | United States | 1.50% |
| Gilead Sciences Inc | US Equity | Healthcare | United States | 1.49% |
| Coca-Cola Co | US Equity | Consumer Goods | United States | 1.48% |
| Apple Inc | US Equity | Technology | United States | 1.47% |
| Merck & Co Inc | US Equity | Healthcare | United States | 1.46% |
| Johnson & Johnson | US Equity | Healthcare | United States | 1.45% |
| Microsoft Corp | US Equity | Technology | United States | 1.44% |
| Procter & Gamble Co | US Equity | Consumer Goods | United States | 1.44% |
| Colgate-Palmolive Co | US Equity | Consumer Goods | United States | 1.43% |
Performance Data
(As of October 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
3.69
|
2.11
|
9.70
|
11.10
|
10.81
|
11.14
|
7.06
|
7.03
|
|
Benchmark
|
-2.46
|
0.98
|
8.34
|
13.84
|
11.64
|
23.67
|
14.78
|
15.91
|
|
Quartile Ranking
|
1
|
1
|
1
|
2
|
2
|
4
|
4
|
4
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
-0.34
|
19.88
|
-4.05
|
1.11
|
18.46
|
-5.95
|
19.10
|
0.73
|
5.81
|
11.70
|
|
Benchmark
|
12.28
|
36.01
|
23.32
|
-12.52
|
28.16
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
|
Quartile Ranking
|
4
|
4
|
4
|
1
|
4
|
4
|
4
|
2
|
4
|
1
|